Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

NCT06021457 is registered in ClinicalTrials.gov with Renibus Therapeutics, Inc. as lead sponsor.

NCT NCT06021457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery
Lead sponsor
Renibus Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 17, 2023
Completion date
June 17, 2025
Enrollment
454 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative complications in cardiac surgery